This month, sales of Zepbound were higher than sales of Wegovy for the first time, even though Zepbound is still not on the formulary for at least one large pharmacy benefit manager
Across the SUSTAIN program, once-weekly subcutaneous semaglutide 1.0 mg reduced HbA 1c by 1.51.8% after 3056 weeks, which was significantly more than sitagliptin, liraglutide, exenatide extended release, dulaglutide, canagliflozin, or insulin glargine
These can help fill nutrition gaps
They help produce weight loss mainly in two ways: They delay stomach emptying, making you feel full and satisfied for longer, even with lesser amounts of food, and they send signals to the brain to reduce hunger and cravings
Three different measurement systems converging on one tiny injection